Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk | Zendy

Philip Urban | Zendy; Ian T. Meredith | Zendy; Alexandre Abizaid | Zendy; Stuart J. Pocock | Zendy; Didier Carrié | Zendy; Christoph Naber | Zendy; Janusz Lipiecki | Zendy; Gert Richardt | Zendy; Andrés Íñiguez | Zendy; Philippe Brunel | Zendy; Mariano ValdésChávarri | Zendy; Philippe Garot | Zendy; Suneel Talwar | Zendy; Jacques Berland | Zendy; Mohamed Abdellaoui | Zendy; Franz R. Eberli | Zendy; Keith G. Oldroyd | Zendy; Robaayah Zambahari | Zendy; John Gregson | Zendy; Samantha Greene | Zendy; HansPeter Stoll | Zendy; MarieClaude Morice | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

Author(s) -

Philip Urban,

Ian T. Meredith,

Alexandre Abizaid,

Stuart J. Pocock,

Didier Carrié,

Christoph Naber,

Janusz Lipiecki,

Gert Richardt,

Andrés Íñiguez,

Philippe Brunel,

Mariano ValdésChávarri,

Philippe Garot,

Suneel Talwar,

Jacques Berland,

Mohamed Abdellaoui,

Franz R. Eberli,

Keith G. Oldroyd,

Robaayah Zambahari,

John Gregson,

Samantha Greene,

HansPeter Stoll,

MarieClaude Morice

Publication year - 2015

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1503943

Subject(s) - medicine , percutaneous coronary intervention , stent , conventional pci , hazard ratio , myocardial infarction , surgery , target lesion , drug eluting stent , confidence interval , clinical endpoint , bare metal stent , randomized controlled trial

Patients at high risk for bleeding who undergo percutaneous coronary intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet therapy. We studied a polymer-free and carrier-free drug-coated stent that transfers umirolimus (also known as biolimus A9), a highly lipophilic sirolimus analogue, into the vessel wall over a period of 1 month.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research